Abstract The optimal method of thromboprophylaxis and the value of screening ultrasonography for detection of deep venous thrombosis (DVT) in neurosurgery patients remains unclear. The goal of this study was to determine the incidence of DVT in neurosurgical patients who, by hospital protocol, receive surveillance ultrasonography of the lower extremities twice weekly, in addition to prophylaxis with unfractionated heparin and external pneumatic compression sleeves. A retrospective review of 7,298 ultrasound studies carried out on 2,593 patients over 4 years at a university neurosurgical hospital was conducted. There was a 7.4% incidence of proximal lower extremity DVT and a 9.7% total incidence including distal DVT. A greater number of distal DVTs were detected with the implementation of whole-leg ultrasonography in the last 2 years of observation. Chart review of 237 patients diagnosed with DVT demonstrated an admitting diagnosis of subarachnoid hemorrhage in nearly half of the patients. The median hospital length of stay for DVT patients was 18 days. Institutional control data demonstrated non-ruptured aneurysm and cerebrovascular anomalies to be the leading reason for admission, followed closely by subarachnoid hemorrhage. The hospital protocol of biweekly screening ultrasound and dual modality prophylaxis for neurosurgery patients resulted in a proximal DVT incidence consistent with that demonstrated by previous studies of standardized dual modality prophylaxis, and higher than that demonstrated in previous studies that employed ultrasound screening protocols.
Introduction
Venous thromboembolism (VTE) is a diagnostic term that encompasses deep vein thrombosis (DVT) and its most serious complication, pulmonary embolism (PE). Best estimates are that 350,000-600,000 Americans develop VTE each year, with PE causing 180,000 deaths annually [1] . Indeed, PE is the number one cause of preventable death in hospitalized patients [2] . There are many published guidelines for VTE prophylaxis, of which those from the American College of Chest Physicians (ACCP) are the most widely used [3] . Yet, only 62% of patients undergoing major surgical procedures at risk for VTE are receiving ACCP-recommended prophylaxis globally [4] . The high incidence of hospital-acquired VTE demonstrates the current gap between evidence-based prophylaxis guidelines and quality measure implementation [5] .
Patients undergoing neurosurgery are considered to be at moderate risk for VTE [2] , with the rate of DVT for combined cranial/spinal procedures performed without prophylaxis varying from 29 to 43% [6] . However, patients with spinal cord injury, malignancy, increasing age, cardiac or respiratory failure, prolonged immobility, and a wide variety of inherited and acquired hematologic conditions are at considerably higher risk [7] . The optimal method of VTE prophylaxis in neurosurgical patients is a matter of controversy. The landmark 1998 study by Agnelli et al. demonstrated the superiority of combined pharmacologic and mechanical prophylaxis over mechanical methods alone in neurosurgical patients, reducing the risk of VTE from 33 to 17% [8] . Several subsequent studies have similarly reported lower rates of VTE with multimodality prophylaxis [9, 10] . However, some neurosurgeons do not use heparin for peri-procedural prophylaxis secondary to concerns of significant bleeding complications [11] .
In 2005, Danish et al. compared the safety and efficacy of pharmacologic anticoagulants with mechanical prophylaxis for craniotomy patients using decision analysis computer modeling to simulate virtual trials based on statistics from published literature [12] . Modeling suggested that the addition of heparin lowered the incidence of both DVT and PE, but at the cost of increasing the rate of intracranial hemorrhage (ICH). The authors concluded that the deleterious effects of ICH are greater than the benefits from pharmacologic anticoagulation on VTE morbidity and mortality, and that overall outcomes are best with mechanical prophylaxis alone. A meta-analysis conducted in 2008 support the findings by Danish et al. [13] .
The current ACCP guidelines recommend that mechanical prophylaxis, using intermittent pneumatic compression devices, be used in neurosurgical patients [2] . Acceptable alternatives to intermittent pneumatic compression devices include postoperative low molecular weight heparin (LMWH) or perioperative low dose unfractionated heparin. For patients who have a particularly high risk of thrombosis, combined mechanical and pharmacologic methods are recommended.
Another area of debate in VTE prophylaxis is surveillance ultrasonography for postoperative neurosurgery patients. The evidence base upon with which standardized DVT surveillance protocols or guidelines can be created is lacking. The natural history of incidentally discovered, asymptomatic DVT is unclear. It is possible that these have a lower propensity to propagate or embolize, and that aggressive treatment in a high bleeding-risk population may provide more harm than benefit. The question of the correct frequency of surveillance screening in neurosurgical patients, or if it should be performed at all, remains unanswered.
The objective of the current study was to retrospectively assess the incidence of lower extremity DVT, as diagnosed by surveillance compression ultrasonography, in the setting of a dual modality prophylaxis regimen aimed at minimizing VTE among neurosurgical patients at the Jefferson Hospital for Neuroscience (JHN) over a 4-year time period.
Jefferson Hospital for Neuroscience is a free-standing university neurosurgical specialty hospital where the standard of care is for patients who are not actively being treated for DVT to have surveillance ultrasound twice weekly, regardless of their clinical status, mobility, diagnosis, or symptoms. In addition, the standard of care calls for all neurosurgical patients to receive, within 24 hours of hospitalization, prophylaxis with external pneumatic compression sleeves and unfractionated heparin (UFH) 5,000 units (U) every 12 hours.
Methods
A retrospective review of ultrasound database records for all neurosurgical patients admitted who had compression ultrasound surveillance of the lower extremity during the 4-year study period, from January 2003 to December 2006, was completed. Total number of lower extremity ultrasound studies performed as well as positivity for lower extremity DVT was collected. Distal (calf vein) versus proximal (popliteal, branches of femoral, or external iliac vein) location of the DVT was recorded.
Prior to 2005, the distal lower extremity was not routinely examined during surveillance ultrasound. In the last 2 years of the data collection period, a change to the standard ultrasound technique was made to include the entire lower extremity, capturing images from the iliac to calf veins and thereby allowing for detection of distal DVT. All upper extremity ultrasound studies were excluded from review. Each patient was counted only once for DVT occurrence during the entire study period, regardless of their number of positive ultrasound scans.
Electronic chart review was possible for 237 of 252 patients identified as positive for lower extremity DVT over the 4-year study period. Data was collected on dates of admission and discharge, as well as primary diagnosis, for these 237 patients. At the time of this study, the medical records in our system were partially computerized and partially paper. As a result, collection of more comprehensive data on each patient was limited. Administrative hospital data was used to estimate an approximate case mix of all patients admitted to the neurosurgical services.
Results
A total of 7,298 ultrasound studies performed on the lower extremities of 2,593 patients were eligible for analysis (Table 1) . Of these patients, 252 (9.7%) were found to have proximal and/or distal lower extremity DVT ( Fig. 1 ; Table 2 ). The number of patients with proximal lower extremity DVT alone was 193 (7.4%). The age distribution of patients with DVT was 18-97 years, with a mean age of 61. Of DVT patients, 42% were male and 58% were female. Three distal DVTs were detected in 2003-2004, while 56 were detected in the 2005-2006. While direct case controls without thrombosis were not available due to the nature of the database search method used, hospitalwide census data revealed a mean patient age of approximately 56 years old.
For 237 patients identified with DVT, subarachnoid hemorrhage (SAH) was the leading primary diagnosis, accounting for 48.5% of cases. ICH was the reason for admission in 11.8% of DVT patients, 11% were admitted with malignancy, and 8.9% with non-ruptured cerebral aneurysm and cerebrovascular anomalies (Table 3) . Among the general neurosurgical population admitted to JHN, the approximate case mix revealed non-ruptured cerebral aneurysm and cerebrovascular anomalies accounted for approximately 30% of admissions, followed by 24% SAH, 8% ICH and 7% malignancy. The DVT population in this study had a larger proportion of patients admitted with SAH, ICH or malignancy as primary diagnosis, and significantly fewer patients admitted with nonruptured aneurysms, when compared to hospital-wide data.
The median length of stay for DVT patients reviewed was 18 days. There was a trend toward decreasing length of stay observed over the 4-year time period. Compared to hospital-wide patient data, DVT patients had longer lengths of stay regardless of primary diagnosis. Most notably, patients with non-ruptured cerebral aneurysms and cerebrovascular anomalies who developed DVTs had longer lengths of stay than other patients with the same diagnosis.
Discussion
The reported incidence of DVT in neurosurgical patients varies widely. The biweekly screening protocol revealed an overall incidence of 7.4% proximal lower extremity DVT and 9.7% total lower extremity DVT in neurosurgical patients where the hospital protocol was to administer prophylaxis with UFH 5,000 U twice daily and external pneumatic compression sleeves within 24 hours of admission.
The proximal DVT rate in our study is consistent with data published from a number of other studies. Nurmohamed et al. examined the incidence of both proximal and total lower extremity DVT in neurosurgical patients. Patients in that study received LMWH (nadroparin) and graduated compression stockings, and by venography were found to have a proximal lower extremity incidence of 7%; however, the incidence of total lower extremity DVT was considerably higher at 19% [14] . Similarly, Agnelli et al. demonstrated an incidence of 5% proximal and 17% total lower extremity DVT, in patients treated with both LMWH (enoxaparin) and compression stockings as detected by venography at treatment day 8 (or sooner if the patient developed symptoms of DVT confirmed by compression ultrasound) [8] . Both of these studies revealed a significant reduction in the rate of DVT when combined prophylactic regimens were employed. In comparison, our study demonstrated a much smaller proportion of distal DVTs detected. Whole-leg ultrasound was not practiced in the first 2 years of our investigation which contributed to lower overall rates of distal DVT. The lower percentage of distal DVT may also be due, in part, to decreased sensitivity of ultrasound when compared to venography employed in the above studies. It is also possible that operator variability, technically limited calf studies, or a learning curve related to change in ultrasound procedure led to decreased [10] . This approach resulted in no patients with symptomatic DVT, but a total lower extremity asymptomatic DVT incidence of 9.3%, very similar to our 9.7% rate of total lower extremity DVT. We were unable to determine symptomatic versus asymptomatic DVT as our investigation was a retrospective review of an ultrasound database, and documentation in the charts reviewed was such that it was not able to be clearly determined. Based on our population and prior studies, we assume the large majority were asymptomatic and detected by the biweekly screening protocol.
Depending on the severity of their condition, many neurosurgical patients may not exhibit signs or express symptoms of thrombosis, so surveillance ultrasound may play a unique role in the early detection of DVT and prevention of PE in this patient population. However, there is conflicting data in the literature regarding propagation rates and long-term clinical significance of distal (calf vein) DVT and the appropriate management of these cases [15] [16] [17] . Screening ultrasound in neurosurgery patients increases diagnosis of asymptomatic calf vein DVT and furthers the debate on appropriate management of these patients at increased risk for intracranial hemorrhage. Hence, it is clear that more large scale prospective studies are needed to help address this issue.
In a similar fashion to our described prophylaxis and surveillance protocol, Misra et al. reviewed routine ultrasound performed twice weekly on 1,094 patients admitted to a neurosurgical intensive care unit [18] . All of these patients were administered DVT prophylaxis in the form of UFH 5,000 U twice daily and sequential compression boots at all times until patients were able to ambulate. The incidence of DVT was 2.55% compared to 5.62% in patients of all other ICUs within the same hospital that did not adhere to a strict prophylactic regimen or screening protocol. Furthermore, there was a very low progression of DVT to PE in the neurosurgical intensive care patients (3.6%) compared to patients in all other intensive care units (19%), suggesting that the neurosurgical intensive care bi-weekly screening protocol helped in the early detection of DVT and prevention of PE. Compared to these studies, the incidence of DVT in our study is higher. This may be related to the larger examined patient population in our study, or possibly a larger proportion of high-risk patients.
Whether it is cost-effective to be screening all neurosurgical patients twice weekly is still unclear. This type of screening protocol employed by Misra et al. was estimated to cost between $1,300 to $1,800 per week [18] . It may be advantageous to follow a screening protocol such as this in only those neurosurgical patients at particularly high-risk. For example, a study of 2,643 neurosurgical patients demonstrated a 7.7% incidence of DVT with routine screening in patients undergoing cranial surgery, but only a 1.5% incidence in spinal surgery patients [19] . The authors suggested that only craniotomy patients require routine screening. Similarly, Ray et al. identified patients who suffered aneurysmal subarachnoid hemorrhage as being a high-risk group for DVT development, having a 24% incidence of asymptomatic DVT [20] . The benefit of routine screening in these high-risk groups, and others like them, likely outweighs concerns of cost-effectiveness. Our results indicate that SAH is one of the most common primary diagnoses at our institution, and in the vast majority of those patients identified with DVT in this study, hence we feel this patient population is generally high-risk, favoring the prophylaxis and surveillance ultrasonography protocol we employ.
There are a number of limitations to this investigation, including its retrospective nature. Mortality, bleeding complication rates, incidence of PE, and the number of diagnostic studies for PE ordered in patients with DVT were not obtained due to the nature of the database employed. Other limitations include an unknown number of patients therapeutically anticoagulated at presentation, or with a prior history of DVT. Patients received a standardized therapy, and there was no control group against which to compare management approaches. Furthermore, the standard of care at JHN calls for all neurosurgical patients to receive, within 24 hours of hospitalization, prophylaxis with external pneumatic compression sleeves and UFH 5,000 U every 12 hours, but it is possible that deviation from this prophylaxis protocol impacted our rates of DVT. Based upon the nature of the available database used, it was not possible to determine which patients had symptomatic versus asymptomatic DVT. There was also no comparison of patients who had specific treatment compared to those without thrombosis. Finally, the only data abstracted was date of admission, discharge, and primary diagnosis.
Obtaining individual demographic information for those patients screened and found to be negative for DVT was beyond the scope of our study. Accordingly, a separate database, which included cases and controls, was used to establish general trends among all patients admitted to JHN for a period of time during our study. Finally, the case mix of this hospital is unique in that it is a free-standing neurosurgical hospital specializing in aneurysm and SAH management, so the generalizability of our data may be limited.
In conclusion, the biweekly screening protocol and dual modality prophylaxis regimen employed in this large neurosurgical population of 2,593 patients over 4 years, dominated by patients with cerebral aneurysms and SAH, yielded a total DVT incidence of 9.7%. Proximal DVT incidence of 7.4% is consistent with that demonstrated by previous studies of standardized dual modality prophylaxis, and higher than that demonstrated in previous studies additionally employing routine screening ultrasound protocols. The use of screening ultrasonography protocols is still debated, and further investigation into whether it is useful and cost-effective to perform screening ultrasounds routinely or in selected high-risk groups within the neurosurgical population is warranted.
